Microbiology Nuts & Bolts
  • Home
  • Basic Concepts
    • What is infection?
    • Normal flora
    • Diagnosing infection
  • Microbiology
    • Basic bacterial identification
    • Interpreting bacteriology results
    • Interpreting serology results
  • Infection Control
    • What is infection control?
    • Universal precautions
    • MRSA
    • Clostridium difficile
  • Clinical Scenarios
    • Respiratory infections
    • Urinary infections
    • GI infections >
      • D&V
      • CDAD
    • CNS infections
    • Skin & bone infections
    • Sepsis
  • Antibiotics
    • Antimicrobial Stewardship
    • How antibiotics work
    • How to choose an antibiotic?
    • Reviewing antibiotics
    • Antibiotic resistance
    • Testing antibiotic resistance
    • Penicillin allergy
    • Theraputic Drug Monitoring
  • Guidelines
  • Lectures & Lecture Notes
    • Medical Students
    • Curriculum for the Foundation Program
    • Foundation Year 1
    • Foundation Year 2
    • Other Lectures
  • The Bug Blog
  • Buy the book...
  • NEW Edition Updates
  • Peer Reviews
  • Our Facebook page
  • Want to know more?
  • Contact

3 Easy Steps to the NEW Dosing Regime for Vancomycin

21/1/2014

 
Vancomycin is a glycopeptide antibiotic commonly used to treat serious infections caused by Gram-positive bacteria, especially Staphylococcus aureus including MRSA. 

The two biggest drawbacks to the use of Vancomycin are:
1) The narrow therapeutic window, i.e. a small range between efficacy and toxicity
2) The difficulty in getting a patient’s blood levels up to therapeutic levels quickly enough, especially when they are septic

The old regime was to use a dose of 1g BD for patients with normal renal function under 65 years old, and 1g OD if they were over 65 years old. Patients with renal failure were given 1g and then re-dosed when their levels were <15mg/L. In practice many microbiologists used to dose younger adults at much higher levels, often 1.25g BD or higher because these patients didn’t reach therapeutic levels on the old regime.
Picture
There is new guidance from both the UK and USA based upon expert opinion that advises us to
use Vancomycin differently. This involves giving an initial loading dose to get patients up to therapeutic levels quickly, and then a dosing regimen specifically based upon their calculated Creatinine Clearance. WARNING: the guideline from the Scottish Antimicrobial Prescribing Group’s “Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion and the Infectious Diseases Society of America is a lot more complicated than before, however read on for 3 easy steps!

New trough levels are also proposed, 10-20mg/L, to avoid the development of Vancomycin resistance in Staphylococcus sp. which may occur due to using low antibiotic levels, e.g. 5mg/L. Previously Microbiologists have advised using 5mg/L for bacteria which have an MIC of ≤1mg/L. However as MIC is usually not known by the clinician, it may be unclear that a Microbiologist has advised this lower dose knowing the MIC. Therefore using 5mg/L is no longer recommended in the guidelines. In time, I believe this may need to be re-evaluated, as the current evidence is only based upon Staphylococci rather than other Gram-positive bacteria such as Streptococci. It may be that using Vancomycin at high levels to treat these other Gram-positive bacteria causes an unacceptable risk of toxicity.
 
The 3 Easy Steps to the new guidance on Vancomycin are as follows:
 
Step 1: Give a Loading Dose
This is based on Actual Body Weight

Vancomycin Loading Dose
Click for larger image
Step 2: Give the Maintenance Dose
The dose and frequency is based on the Calculated Creatinine Clearance (CrCl). Dose Intervals are either 12, 24 or 48 hours after the Loading Dose.
 
Use the Cockcroft Gault equation to give a Calculated Creatinine Clearance (CrCl)
CrCl Equation
Click for larger image
WARNING: you MUST use the CALCULATED CREATININE CLEARANCE figure not the Creatinine value as the Creatine value does not give an accurate reflection of renal function on its own.
Vancomycin Maintenance Dose
Click for larger image
Try these examples:
Vancomycin examples
Click for larger image
Try again:
Vancomycin Examples
Click for larger image
Step 3: Measure the Trough Level
A Trough level should be taken within 48 hours of starting treatment (e.g. just before the 4th Maintenance Dose if on 12 hourly Dose Interval or just before the 1st Maintenance Dose if on 48 hourly Dose Interval), THEN at least every 3 days if stable renal function, to reach the target 10-20mg/L
(15-20mg/L in severe or deep-seated infections). 

Note: Take Trough levels more frequently (i.e. just before every dose) in changing renal function.
Vancomycin Trough Levels
Click for larger image
Test yourself:
Vancomycin Examples
Click for larger image
Whilst this may appear more complicated the new regime should benefit patients by making sure they achieve therapeutic levels of Vancomycin as quickly as possible.

BE AWARE the new dosing regimen does have a potential drawback. In a comparison study (Ref. 2) of the predicted trough levels comparing the old regime to the new regime, a small number of patients (3%) were predicted to have potentially toxic levels (>20mg/L) with this new regime compared to the old. However, the new regime ensures a much higher proportion of patients (77%) achieved therapeutic levels (10-20mg/L) at the time of their first trough level compared with the old regime (26%). This on balance has swung the guidance in favour of the new regime.

References
  1. Scottish Antimicrobial Prescribing Group, Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion 2013
  2. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Thomson A, Staatz C, Tobin C
    et al. J Antimicrob Chemother 2009; 63: 1050-1057
  3. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious    
    Diseases Pharmacists. Rybak M, Lomaestro B, Rotschafer J et al. Am J Health-Syst Pharm 2009; 66: 82-98

Comments are closed.

    RSS Feed

    Blog Author:

    David Garner
    Consultant Microbiologist
    Surrey, UK

    Please DO NOT advertise products and conferences on our website or blog

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    Archives

    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    October 2013
    September 2013
    August 2013
    July 2013

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    RSS Feed

Powered by Create your own unique website with customizable templates.